ormative data collection and Software Development for RS-3000

Not Applicable

• Conditions: Healthy individuals

• Registration Number: JPRN-UMIN000002393
• Lead Sponsor: Department of Ophthalmology & Visual Sciences, Kyoto University Graduate School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-09-01
• Study Completion: 2010-01-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 288

Inclusion Criteria

Not provided

Exclusion Criteria

1) Exclusion criteria regarding systemic disease a)a) Diabetes mellitus b)b) Uncontrollable hypertension c)c) Cerebral infarction, cerebral hemorrhage, cranial nerve neoplasm and other central nervous system diseases affecting vision d)d) Cardiac, hepatic, renal and hematologic diseases, and other moderate to severe complications e)e) During systemic administration of steroid f)f) History of anticancer agent etc. g)g) Optically-stimulated epileptic seizure h)h) Dementia i)i) Other serious systemic diseases 2) Exclusion criteria regarding ocular disease a)a) History of keratorefractive surgery b)b) History of retinal photocoagulation c)c) History of intraocular surgery 3) Exclusion criteria regarding qualifying examination. 4) Exclusion criteria regarding OCT imaging Subjects who can or could have any difficulty associated with OCT data acquisition

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To demonstrate the three-dimensional distribution of macular thickness in normal subjects by spectral domain optical coherence tomography (SD-OCT), and to evaluate the association between macular thickness and sex, age, axial length, and race.